New Radiation Oncology Partnership Announced at the Shady Grove Aquilino Cancer Center

Published on October 16, 2023

Gaithersburg, Maryland – Adventist HealthCare announces a new radiation oncology joint venture partnership with US Oncology Network, a leading oncology provider, at the Shady Grove Aquilino Cancer Center.

This partnership deepens the relationship with top oncology experts at Maryland Oncology Hematology and is backed by the US Oncology Network, with 500 sites of care throughout the U.S, giving patients more access to the latest clinical trials, treatment and advanced technology.

Adventist HealthCare and Maryland Oncology Hematology have closely collaborated for many years and were key partners in the opening of the Aquilino Cancer Center in 2013. The relationship has deepened through a separate radiation oncology joint venture partnership at the White Oak Cancer Center in 2020. This new agreement will now align the most advanced care practices at both cancer centers to improve outcomes and patient experience, providing world-class cancer treatment in the Washington, D.C., region.

Kashif Firozvi, MD, Medical Director of the Cancer Service Line at Adventist HealthCare and a lead physician at Maryland Oncology Hematology states, “the partnership at the Aquilino Cancer Center and at White Oak Cancer Center has established Adventist HealthCare and Maryland Oncology Hematology as the largest and most advanced radiation oncology program in Montgomery County. Together, we are bringing new state-of-the-art technology and treatment for radiation oncology that is more targeted, offers decreased treatment times and lower side effects, thereby enhancing patient care and improving outcomes.”

Using the Varian TrueBeam®, one of the most advanced radiation oncology treatment technologies available, treatment is precise and targeted to save healthy tissues and cells. With access to the latest radiation oncology treatment that is close to home and with all their cancer care in one place, patients can spend less time worrying about coordinating appointments and more time with family and focusing on healing.

Established in 2013 as the first stand-alone cancer center in Montgomery County, the Aquilino Cancer Center has offered groundbreaking treatment throughout its 10-year history. The new partnership with US Oncology and Maryland Oncology Hematology enhances the high-quality interdisciplinary cancer care services already offered within the center. With medical oncology/hematology, radiation oncology, surgical oncology, PET/CT imaging, genetics, research, rehabilitation, social work, cancer navigation and wellness resources all in one location, the Aquilino Cancer Center is a regional leader in cancer care. “As we build on our history of healing, we are excited to partner with Maryland Oncology Hematology and US Oncology and continue to bring world-class cancer care to the Washington, D.C., region,” says Aaron Cohen, President, Physician Enterprise at Adventist HealthCare.

Adventist HealthCare, based in Gaithersburg, Maryland, is one of the longest-serving health systems in the Washington, D.C., region. It includes Shady Grove Medical Center, White Oak Medical Center, Fort Washington Medical Center, Adventist HealthCare Rehabilitation, Home Care Services, Adventist Medical Group, Imaging and Cardiac Associates. Our mission is to extend God’s care through the ministry of physical, mental, and spiritual healing.

About US Oncology Network

Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 95 FDA-approved cancer therapies.

About Maryland Oncology Hematology

Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical oncology, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers.

New Radiation Oncology Partnership Announced at the Shady Grove Aquilino Cancer Center

Media Contact